National Advisory Board

The BayMark National Advisory Board consists of national leaders and subject matter experts convened to provide leading edge guidance and support to BayMark in its work providing treatment and recovery solutions to individuals, families and communities affected by the opioid epidemic. The National Advisory Board helps substantiate and guide the Mission, Vision and Values of BayMark and works to continue to reduce stigma and discrimination toward those with opioid use disorders, while improving cultural and gender responsiveness, research, and positive outcomes across the field.

Kathryn Thomas
Jim Clarkson, MA, LADAC

Read Mr. Clarkson’s Bio

Frank Baumann
Sam Donaldson, Ph.D.

Read Dr. Donaldson’s Bio

Jason Kletter, Ph.D.
Pamela Hyde, JD

Read Dr. Hyde’s Bio

Daniel Gutschenritter
Hendree Jones, Ph.D.

Read Dr. Jones’ Bio

Sheldon Glass, M.Ed., M.D.
Jeanne Miranda, Ph.D.

Read Dr. Miranda’s Bio

Michelle Kletter
Paul Rosenberg, JD

Read Dr. Rosenberg’s Bio

Kathryn Thomas
David K. White, Ph.D.

Read Dr. White’s Bio

© BayMark 2018

Designed by StarFlame Solutions, LLC